Evidence map›Paper›PMID 37502395›Full record

ArticleFrontiers in microbiology2023

Rapid and visual identification of HIV-1 using reverse transcription loop-mediated isothermal amplification integrated with a gold nanoparticle-based lateral flow assay platform.

Xu Chen, Cheng Du, Qiang Zhao, Qi Zhao, Yonghu Wan, Jun He, Wei Yuan

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Xu Chen *The Second Clinical College, Guizhou University of Traditional Chinese Medicine, Guiyang, Guizhou, China.
Cheng Du *Department of Anesthesiology, The Second Affiliated Hospital, Guizhou University of Traditional Chinese Medicine, Guiyang, Guizhou, China.
Qiang ZhaoClinical Laboratory, Guizhou Provincial Center for Clinical Laboratory, Guiyang, Guizhou, China.
Qi ZhaoGastroenterology of the Second Affiliated Hospital, Guizhou University of Traditional Chinese Medicine, Guiyang, Guizhou, China.
Yonghu WanExperiment Center, Guizhou Provincial Centre for Disease Control and Prevention, Guiyang, Guizhou, China.
Jun HeClinical Laboratory, Guizhou Provincial Center for Clinical Laboratory, Guiyang, Guizhou, China.
Wei YuanDepartment of Quality Control, Guizhou Provincial Center for Clinical Laboratory, Guiyang, Guizhou, China.
Affiliated Hospital of Guizhou Medical University · CNGuizhou University · CNGuizhou Center for Disease Control and Prevention · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human immunodeficiency virus type one (HIV-1) infection remains a major public health problem worldwide. Early diagnosis of HIV-1 is crucial to treat and control this infection effectively. Here, for the first time, we reported a novel molecular diagnostic assay called reverse transcription loop-mediated isothermal amplification combined with a visual gold nanoparticle-based lateral flow assay (RT-LAMP-AuNPs-LFA), which we devised for rapid, specific, sensitive, and visual identification of HIV-1. The unique LAMP primers were successfully designed based on the

Indexed as

gold nanoparticle-based lateral flow assayhuman immunodeficiency virus type onelimit of detectionloop-mediated isothermal amplificationpoint-of-care platform

Identifiers

PMID37502395
PMCPMC10368893
OpenAlexW4384072385

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.